Surgical-site infection after hip fracture surgery: preoperative full-body disinfection compared to local disinfection of the surgical site-a population-based observational cohort study.


Journal

European geriatric medicine
ISSN: 1878-7649
Titre abrégé: Eur Geriatr Med
Pays: Switzerland
ID NLM: 101533694

Informations de publication

Date de publication:
10 2022
Historique:
received: 23 12 2021
accepted: 21 03 2022
pubmed: 9 4 2022
medline: 14 10 2022
entrez: 8 4 2022
Statut: ppublish

Résumé

Swedish national guidelines recommend full-body disinfection (FBD) with 4% chlorhexidine before hip fracture surgery to prevent surgical-site infection (SSI) despite little evidence. Our objective was to compare preoperative FBD with local disinfection (LD) of the surgical site regarding SSI incidence. All patients with hip fracture, operated at a hospital in Sweden, January 1, 2018 to December 31, 2019 were included. Patients in 2018 (n = 237) were prepared with FBD and patients in 2019 (n = 259) with LD. Primary outcome was SSI and secondary outcome was SSI and/or death. We adjusted for potential confounders with logistic regression. The adjusted analysis was performed in two models to enable assessment of variables that lacked either outcome; in the first model, these variables were not adjusted, and the second model was restricted to a sub-population not affected by respective variables. There were 16 (6.8%) cases of SSI in 2018 and 8 (3.1%) cases in 2019. FBD (2018) compared to LD (2019) presented an adjusted OR of 1.9 (95%CI 0.8-4.9, P = 0.16) respectively 2.0 (95%CI 0.8-5.1, P = 0.14) in the two models of the logistic regression. In addition, 40 (16.9%) patients in 2018 and 29 (11.2%) patients in 2019 had the combined outcome of SSI and/or death, adjusted OR 1.6 (95% CI 0.9-2.8, P = 0.08) respectively 1.7 (95% CI 0.9-2.9, P = 0.06). We found a non-significant increased risk of SSI 2018 compared to 2019 after adjustment. Randomized control trials are needed. Nonetheless, results suggest that LD is not inferior to FBD regarding SSI prevention, meaning patients could potentially be spared substantial pain.

Identifiants

pubmed: 35391660
doi: 10.1007/s41999-022-00640-6
pii: 10.1007/s41999-022-00640-6
pmc: PMC9553784
doi:

Substances chimiques

Chlorhexidine R4KO0DY52L

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1097

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

J Bone Joint Surg Br. 2012 Feb;94(2):237-40
pubmed: 22323693
J Hosp Infect. 2013 Jun;84(2):151-8
pubmed: 23623487
J Invest Surg. 2020 Sep;33(8):750-758
pubmed: 30885013
Injury. 2012 Jul;43(7):1182-6
pubmed: 22542166
Injury. 2016 Sep;47 Suppl 3:S56-S60
pubmed: 27692108
J Clin Orthop Trauma. 2019 Sep-Oct;10(5):904-911
pubmed: 31528066
Eur J Trauma Emerg Surg. 2019 Apr;45(2):207-212
pubmed: 29340736
Am J Infect Control. 2017 Apr 1;45(4):343-349
pubmed: 28109628
J Hosp Infect. 2015 Feb;89(2):82-9
pubmed: 25575769
Orthop Traumatol Surg Res. 2013 Oct;99(6):659-65
pubmed: 24029588
J Arthroplasty. 2013 Mar;28(3):490-3
pubmed: 23114192
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96
pubmed: 10196487
Clin Epidemiol. 2021 Jan 12;13:21-41
pubmed: 33469380
Int Orthop. 2009 Oct;33(5):1179-87
pubmed: 19343344
Clin Orthop Relat Res. 2008 Jul;466(7):1710-5
pubmed: 18421542
Bone Joint J. 2017 Aug;99-B(8):1088-1094
pubmed: 28768787
J Bone Joint Surg Br. 2008 Jun;90(6):770-7
pubmed: 18539671
Acta Orthop. 2020 Jun;91(3):347-352
pubmed: 31973621
Acta Orthop. 2011 Dec;82(6):646-54
pubmed: 22066562
Int Orthop. 2016 Sep;40(9):1843-8
pubmed: 26611729
Int Orthop. 2007 Aug;31(4):483-5
pubmed: 16909250
Ann Chir Gynaecol. 1987;76(5):263-5
pubmed: 3324917
J Hosp Infect. 1988 May;11(4):310-20
pubmed: 2899582
Infect Control Hosp Epidemiol. 2014 Dec;35(12):1491-6
pubmed: 25419771
Microorganisms. 2020 Dec 12;8(12):
pubmed: 33322779
Medicine (Baltimore). 2019 Mar;98(11):e14882
pubmed: 30882697
J Hosp Infect. 2006 Jan;62(1):44-9
pubmed: 16221508
Am J Infect Control. 2019 May;47(5):540-544
pubmed: 30554880
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
J Orthop Surg Res. 2019 Nov 21;14(1):382
pubmed: 31752900
Cochrane Database Syst Rev. 2015 Feb 20;(2):CD004985
pubmed: 25927093
Injury. 2021 Apr;52(4):898-904
pubmed: 33082026

Auteurs

Noelle Probert (N)

Faculty of Medicine and Health, Örebro University, Örebro, Sweden. noelle.probert@oru.se.
Centre of Clinical Research, Region Värmland, Karlstad, Sweden. noelle.probert@oru.se.

Åsa G Andersson (ÅG)

Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Department of Geriatrics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Anders Magnuson (A)

Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

Elin Kjellberg (E)

Department of Infectious Diseases, Central Hospital of Kristianstad, Kristianstad, Sweden.

Per Wretenberg (P)

Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Department of Orthopaedics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH